Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/9CD7F6F0.svg?ark=w1%2F20260515%2F9CD7F6F0)](https://nobleid.org/work/w1/20260515/9CD7F6F0)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors